By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Newron Pharmaceuticals 

Via R. Lepetit
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333



Company News
Newron Pharma (NWRN) Release: XADAGO (Safinamide) Now Available In The U.S. For Parkinson’s Disease Patients 7/11/2017 6:33:37 AM
Newron Pharma (NWRN) Announces A Poster Presentation At The International Society For Pharmacoeconomics And Outcomes Research (ISPOR) 22nd Annual International Meeting 5/18/2017 6:32:29 AM
Newron Pharma (NWRN) Announces Expansion Of STARS Study To Include Patients Under 13 Years Of Age 5/17/2017 7:06:48 AM
Newron Pharma (NWRN) Receives EUR11.3 Million Milestone Payments For US Approval Of Xadago (Safinamide) 5/12/2017 6:22:21 AM
Newron Pharma (NWRN) Shareholders Confirm Company Management 3/28/2017 11:23:20 AM
Newron Pharma (NWRN) Presents Encouraging Detailed Results Of Its Phase IIa Study With Evenamide In Patients With Schizophrenia 3/27/2017 6:55:50 AM
Why Newron Pharma (NWRN)'s Newly Approved Parkinson's Drug Isn't All That Novel 3/23/2017 6:51:35 AM
Newron Pharma (NWRN) Release: FDA Approves Xadago (Safinamide) For Parkinson's Disease (PD) Patients 3/22/2017 6:51:57 AM
Newron Pharma (NWRN) To Present At The 16th International Congress On Schizophrenia Research 3/16/2017 6:47:23 AM
Newron Pharma (NWRN) Announces 2016 Financial Results And Provides Outlook For 2017 3/2/2017 6:24:18 AM